Top-level global management of licensed and native neuromodulation intellectual property

Finnegan was selected to supervise the identification and development of native intellectual property (IP) and the oversight of the licensed IP of numerous academic partners in the U.S. and Europe.  As an ongoing exercise, the company’s portfolio is landscaped in the context of the industry for business, legal and research and development (R&D) decisionmakers.  Identification of acquisition candidates and targets for both in- and out-licensing is based on current information from these activities. New product development risks are also mitigated by leveraging an up-to-date understanding of competitors’ IP positions.